|By Marketwired .||
|July 14, 2014 06:01 PM EDT||
BURNABY, BRITISH COLUMBIA -- (Marketwired) -- 07/14/14 -- In a press release dated June 26, NSE incorrectly identified Boreal Technologies' role in a licensing opportunity for cannabinoid related technologies. The corrected information is provided below. We apologize for any confusion this may have created.
Naturally Splendid Enterprises (the "Company") (TSX VENTURE: NSP) (OTC PINK: NSPDF) (FRANKFURT: 50N) is pleased to announce that the Company is now evaluating multiple opportunities in the commercialization of industrial hemp and extracted cannabinoids for the creation of branded nutraceutical products. In addition to the already established revenue streams from the NATERA hemp based superfood retail line and its developing biotech food division in partnership with Boreal Technologies, the Company is optimistic with the multitude of opportunities in the nutraceutical cannabinoid market.
Naturally Splendid is currently in advanced stage discussions with Full Spectrum Laboratories, Ltd. out of Dublin, Ireland, regarding licensing of new nutraceutical cannabinoid technologies. These nutraceutical cannabinoid technologies include Cannabidiol (CBD) known for its multiple therapeutic applications without the "stoned" effect of THC found in marijuana. This strategy is restricted to the United States until other jurisdictions explicitly permit cannabinoid therapies.
CEO Craig Goodwin states, "We are developing business strategies designed to investigate, evaluate and where there is a strong business case, develop additional products and markets unlocking all potential revenue opportunities within the industrial hemp crop. The area of nutraceutical cannabinoids is increasingly interesting to Naturally Splendid, especially when you consider the advanced science being developed by Full Spectrum. This potential creation of a new relationship with Full Spectrum to include Naturally Splendid's branded nutraceutical cannabinoid products legally derived from industrial hemp, will allow Naturally Splendid to participate more directly in this nutraceutical market in the United States."
Charlie Brink, Chairman of Full Spectrum Laboratories states, "We're excited to see Naturally Splendid explore the opportunities available in the nutraceutical cannabinoid market space. We look forward to progressive dialogue on potential business opportunities for our companies in licensed jurisdictions. What we've discovered is that Cannabis sativa (industrial hemp) is a wholly misunderstood plant. Our team has identified compounds within this plant that have great nutraceutical and nutritional properties. Many of these have translated into unique ingredients that most people haven't seen before. We've spent a pain-staking amount of time assembling the right kind of talent to bring these products to market and execute our business strategy. There is now an exciting opportunity before us to be able to take the science and the research that has been conducted in the laboratory in the past few years and create products that we can bring to market that will help people and enhance their lives."
Cannabis Sativa is a species which includes industrial hemp and marijuana. Cannabis Sativa is used in food, nutraceutical products as well as medicinal applications. Both plants share many of the same active chemicals and cannabinoids. A prominent cannabinoid present in industrial hemp is Cannabidiol (CBD) known for its multiple therapeutic, nutraceutical applications. More specifically, Cannabidiol, or CBD, is a compound in industrial hemp that potentially has significant medical benefits, but does not make people feel "high" and can actually counter the psychoactivity of THC. The reduced psychoactivity of CBD-rich cannabis may make it an appealing nutraceutical product for individuals seeking anti-inflammatory, anti-pain, anti-fungal, anti-bacteria and/or anti-spasm effects without disconcerting lethargy or dysphoria.
Naturally Splendid Co-founder Bryan Carson states, "There has been much in the news recently surrounding the functional, nutraceutical and pharmaceutical applications of the multiple cannabinoids prevalent in industrial hemp. Changing legislation in the United States is most definitely a driving factor in the increased attention that has been focused on the cannabinoid opportunities."
About Full Spectrum
Full Spectrum Laboratories, Ltd., based out of Dublin, Ireland, is a privately-held biotechnology company specializing in the scientific research, development and commercialization of its technologies and services. Full Spectrum owns a portfolio of patented and patent-pending cannabinoid-based technologies including breeding, analytical services, extraction and formulation. Full Spectrum strategically identifies global partners for licensing opportunities in the pharmaceutical and nutraceutical markets. Our technologies enable companies to have access to pharmaceutical-grade cannabinoids for the development of cannabinoid based therapeutics, industrial solutions and consumer goods.
Full Spectrum has licensed certain formulation technologies focused on omega-fatty acids and proteins to Boreal Technologies. This Agreement will continue separately and independently of any license agreement Full Spectrum may enter with Naturally Splendid for cannabinoid formulation technologies.
About Boreal Technologies
Boreal Technologies Inc., located on the University of British Columbia campus in Vancouver, B.C., is a specialized product solution and service provider with customers in North America and Asia. Boreal offers a comprehensive range of product development and analytical testing services to the nutraceutical, agricultural and consumer product industries. Our patent-pending process technologies enable companies to bring new; value-added products to market that are enhanced with scientifically-proven, superior functional ingredients.
About Naturally Splendid Enterprises Ltd.
Naturally Splendid's 100% owned NATERA line of hemp-based superfood products are carried nationwide by Canada's leading health food distributors and a network of retail stores across Canada including major retailers and specialty stores. Naturally Splendid's recently rebranded "NATERA" line of products includes natural and flavored shelled hemp seeds as well as natural and flavored hemp protein powders.
Naturally Splendid has an exclusive sales agreement to market and distribute, in North America, the full complement of patent pending, plant-based omega products created by Boreal Technologies. The products include HempOmega and H2Omega, as well as the FlaxOmega, CanolaOmega, and ChiaOmega plant based omega products. These novel products utilize microencapsulation and are available in both a powder format and an aqueous solution for increased flexibility in ingredient applications and stand-alone products.
J. Craig Goodwin, CEO & Director
Forward-Looking Statements: Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management's current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. Naturally Splendid cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Naturally Splendid's control. Such factors include, among other things: risks and uncertainties relating to the successful testing and evaluation H2Omega and HempOmega by Calico. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Naturally Splendid undertakes no obligation to publicly update or revise forward-looking information.
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.
Jan. 16, 2017 01:00 PM EST Reads: 3,596
Updating DevOps to the latest production data slows down your development cycle. Probably it is due to slow, inefficient conventional storage and associated copy data management practices. In his session at @DevOpsSummit at 20th Cloud Expo, Dhiraj Sehgal, in Product and Solution at Tintri, will talk about DevOps and cloud-focused storage to update hundreds of child VMs (different flavors) with updates from a master VM in minutes, saving hours or even days in each development cycle. He will also...
Jan. 16, 2017 01:00 PM EST Reads: 1,003
Jan. 16, 2017 12:45 PM EST Reads: 257
"There's a growing demand from users for things to be faster. When you think about all the transactions or interactions users will have with your product and everything that is between those transactions and interactions - what drives us at Catchpoint Systems is the idea to measure that and to analyze it," explained Leo Vasiliou, Director of Web Performance Engineering at Catchpoint Systems, in this SYS-CON.tv interview at 18th Cloud Expo, held June 7-9, 2016, at the Javits Center in New York Ci...
Jan. 16, 2017 12:30 PM EST Reads: 5,419
The 20th International Cloud Expo has announced that its Call for Papers is open. Cloud Expo, to be held June 6-8, 2017, at the Javits Center in New York City, brings together Cloud Computing, Big Data, Internet of Things, DevOps, Containers, Microservices and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding business opportunity. Submit your speaking proposal ...
Jan. 16, 2017 12:30 PM EST Reads: 4,985
@DevOpsSummit taking place June 6-8, 2017 at Javits Center, New York City, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @DevOpsSummit at Cloud Expo New York Call for Papers is now open.
Jan. 16, 2017 12:30 PM EST Reads: 3,336
A look across the tech landscape at the disruptive technologies that are increasing in prominence and speculate as to which will be most impactful for communications – namely, AI and Cloud Computing. In his session at 20th Cloud Expo, Curtis Peterson, VP of Operations at RingCentral, will highlight the current challenges of these transformative technologies and share strategies for preparing your organization for these changes. This “view from the top” will outline the latest trends and developm...
Jan. 16, 2017 12:30 PM EST Reads: 787
Jan. 16, 2017 12:00 PM EST Reads: 1,340
Jan. 16, 2017 12:00 PM EST Reads: 2,381
Jan. 16, 2017 11:30 AM EST Reads: 1,842
Jan. 16, 2017 11:30 AM EST Reads: 4,120
Jan. 16, 2017 11:30 AM EST Reads: 5,660
Jan. 16, 2017 11:27 AM EST Reads: 204
Jan. 16, 2017 11:15 AM EST Reads: 1,708
Jan. 16, 2017 10:15 AM EST Reads: 7,629